ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2013 American Transplant Congress

    Functional and Quality of Life Outcomes at One Year after Successful Bilateral Hand Transplant

    G. Sisk, M. Benjamin, M. Carty, C. Sampson, J. Pribaz, P. Blazar, B. Earp, G. Dyer, B. Pomahac, S. Talbot

    Division of Plastic Surgery, Brigham and Women's Hospital, Boston, MA; Department of Rehabilitation Services, Brigham and Women's Hospital, Boston, MA; Department of Plastic Surgery, Children's Hospital, Boston, MA; Department of Orthopedic Surgery, Brigham and Women's Hospital, Boston, MA

    Background: Upper limb loss has severe consequences with regard to functional status and mental health. Prostheses, though sophisticated, lack sensory feedback and appear unnatural. Upper…
  • 2013 American Transplant Congress

    HLA-DR Mismatching Is Not Associated with Decreased Graft Survival in Highly Sensitized Kidney Recipients

    R. Ruhil, S. Talebagha, J. Beus, T. Pearson, H. Gebel, R. Bray, N. Turgeon

    Emory Transplant Center, Atlanta

    Background: HLA mismatches, especially those at the HLA-DR locus, are reported to influence allograft survival. In this single center study the effect of HLA-DR matching…
  • 2013 American Transplant Congress

    Outcomes of Persistent EBV Viremia Post Transplant in Pediatric Renal Allograft Recipients: Effects of Rituximab Treatment

    D. Puliyanda, M. Toyoda, M. Patel, N. Reinsmoen, E. Kamil, S. Jordan

    Pediatric Nephrology and Transplant Immunology Laboratory, Cedars Sinai Medical Center, Los Angeles, CA

    Post-Tx lymphoproliferative disorder (PTLD), usually caused by EBV, is a serious complication in renal Tx patients (pts), and a correlation between persistent EBV viremia (PEBV)…
  • 2013 American Transplant Congress

    Protocol Biopsies Are Valuable in High Immunologic Risk Patients

    S. Patel, S. Mohan, R. Crew, Z. Zaky, D. Tsapepas, L. Ratner

    Surgery, Columbia University, New York; Nephrology, Columbia University, New York

    INTRODUCTION: The utility of protocol allograft biopsies (at prespecified intervals regardless of allograft function) remains unclear even in patients with elevated immunological risk such as…
  • 2013 American Transplant Congress

    Serum Changes in FGF23 and Biochemical Biomarkers of Bone Mineral Disorder in Children after Renal Transplantation

    M. Medeiros, J. Rico, P. García-Roca, A. Hernández, L. Ortiz, R. Aldana, D. Díaz-Barriga, S. Valverde, F. Velásquez-Forero

    Hospital Infantil de México Federico Gomez, Mexico, DF, Mexico

    Successful renal transplantation improves chronic kidney disease-mineral and bone disorder in children, nevertheless several factors contribute to persistent bone disorder in transplant recipients such as…
  • 2013 American Transplant Congress

    Long Term Outcomes and Quality of Life of Live Liver Donors. A Single Center Experience

    V. Humphreville, T. Pruett, J. Lake, R. Kandaswamy, W. Payne, S. Chinnakotla, D. Radosevich

    Dept Surg, U of MN, Mpls, MN

    Purpose: Short term outcomes of live liver donors are well described; however there are few reports on long term outcomes and quality of life (QoL).…
  • 2013 American Transplant Congress

    Novel Strategy To Prevent HCV Re-Infection Post Liver Transplantation: Anti-E1/E2 Monoclonal Antibody and Epigallocatechin Gallate (EGCG) in Combination, A

    D. O'Shea, J. Law, A. Egli, L. Lisboa, D. Kumar, L. Tyrrell, M. Houghton, N. Kneteman, A. Humar

    University of Alberta, Edmonton, Canada

    Background: Prophylaxis against HCV infection of the naÏve allograft is integral to efforts to improve outcomes in HCV positive liver transplant recipients. To effectively achieve…
  • 2013 American Transplant Congress

    Validating the Microarray Test for T Cell-Mediated Rejection in Biopsies in a Prospective Trial: The INTERCOM Study

    A. Pereira, J. Reeve, J. Chang, A. Matas, D. de Freitas, J. Bromberg, J. Sellares, G. Einecke, P. Halloran

    University of Alberta, Edmonton, Canada; University of Minnesota, Minneapolis; Manchester Royal Infirmary, Manchester, United Kingdom; University of Maryland School of Medicine, Baltimore; Hospital de la Vall d'Hebron, Barcelona, Spain; Medical School of Hannover, Hannover, Germany

    We previously reported a microarray-based test for T cell-mediated rejection (TCMR) in biopsies from renal transplants. To validate this test, we undertook a prospective international…
  • 2013 American Transplant Congress

    Thromboembolic Events Are Increased in Heart and Lung Transplant Recipients Who Received Intra-Operative Recombinant Factor VIIa

    K. Schoeppler, J. Lindenfeld, D. Lyu, T. Grazia, J. Crossno, Jr, K. Vandervest, M. Zamora

    Pharmacy, Univ of CO Hospital, Aurora, CO; Cardiology, Univ of CO Medical Campus, Aurora; Pulmonary and Critical Care, Univ of CO Medical Campus, Aurora

    Recombinant Factor VIIa (rFVIIa) is often used intra-operatively for refractory bleeding in heart and lung transplant recipients (HTxR, LTxR). While this off-label use may help…
  • 2013 American Transplant Congress

    Use of Continuous Glucose Monitoring (CGM) in the Evaluation of Auto-Islet Candidates

    H. Rilo, M. Delbridge, B. Grigsby, A. Rana, M. Porubsky, A. Gruessner, R. Gruessner

    Surgery, University of Arizona, Tucson, AZ

    Purpose: We used continuous glucose monitoring (CGM) as a comparative tool with glycated hemoglobin A1c (HbA1c) to assess metabolic function in auto-islet transplant candidates.Methods: From…
  • « Previous Page
  • 1
  • …
  • 1624
  • 1625
  • 1626
  • 1627
  • 1628
  • …
  • 1683
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences